Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Cristina Oliva
Lapatinib Plus Capecitabine in Women With HER-2-Positive Advanced Breast Cancer: Final Survival Analysis of a Phase III Randomized Trial
Oncologist
Cancer Research
Medicine
Oncology
Leishmania Infantum EndoG Is an Endo/Exo-Nuclease Essential for Parasite Survival
PLoS ONE
Multidisciplinary
Related publications
Lapatinib Plus Capecitabine for HER2-Positive Advanced-Stage Breast Cancer in Elderly Women: Review of the Anatolian Society of Medical Oncology (ASMO) Experience
Breast Care
Surgery
Oncology
Randomized Phase III Placebo-Controlled Trial of Letrozole Plus Oral Temsirolimus as First-Line Endocrine Therapy in Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Lapatinib-Capecitabine Versus Capecitabine Alone as Radiosensitizers in RAS Wild-Type Resectable Rectal Cancer, an Adaptive Randomized Phase II Trial (LaRRC Trial): Study Protocol for a Randomized Controlled Trial
Trials
Medicine
Pharmacology
Phase II Trial of Fulvestrant With Metronomic Capecitabine for Postmenopausal Women With Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer
Clinical Breast Cancer
Cancer Research
Oncology
Interim Analysis of Postoperative Chemoradiotherapy With Capecitabine and Oxaliplatin Versus Capecitabine Alone for Pathological Stage II and III Rectal Cancer: A Randomized Multicenter Phase III Trial
Oncotarget
Oncology
Independent Review of E2100: A Phase III Trial of Bevacizumab Plus Paclitaxel Versus Paclitaxel in Women With Metastatic Breast Cancer
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
A Phase II Trial of Fixed-Dose Rate Gemcitabine Plus Capecitabine in Metastatic/Advanced Biliary Tract Cancer Patients
Oncology
Medicine
Cancer Research
Oncology
Palbociclib With Letrozole in Postmenopausal Women With ER+/HER2− Advanced Breast Cancer: Hematologic Safety Analysis of the Randomized PALOMA‐2 Trial
Oncologist
Cancer Research
Medicine
Oncology
A Phase I Trial of Combination Trastuzumab, Lapatinib, and Bevacizumab in Patients With Advanced Cancer
Investigational New Drugs
Oncology
Pharmacology
